Simon Cooper's Insider Trades & SAST Disclosures
Simon Cooper's most recent trade in Morphic Holding Inc was a trade of 170,000 Employee Stock Options (right to buy) done . Disclosure was reported to the exchange on March 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Simon Cooper.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Morphic Holding Inc | Simon Cooper | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 170,000 | 170,000 | - | - | Employee Stock Options (right to buy) | |
| Morphic Holding Inc | Simon Cooper | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 14,000 | 14,000 | - | - | Restricted Stock Unit | |
| Morphic Holding Inc | Simon Cooper | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 7,000 | 7,000 | - | - | Restricted Stock Unit | |
| Keros Therapeutics Inc | Cooper Simon | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
| Keros Therapeutics Inc | Simon Cooper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
| Keros Therapeutics Inc | Simon Cooper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Keros Therapeutics Inc | Simon Cooper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges